Having a heart and brain for the community – ASU Now

January 25, 2021

Alma Alyssa Manzo was hooked the first time she saw a scientist holding a human brain in their hands. As a sophomore, Manzo saw a graduate student holding a brain at a research lab fair and knew she had to learn more. The introduction to neuroscience and aging kicked into full gear when she began working on transgenic models.

Manzo now plans to go into a nursing PhD program to help instruct caregivers in diverse populations about how to take care of patients with Alzheimers, dementia and mild cognitive impairments. Alma Alyssa Manzo, a senior in the Arizona State University Department of Psychology who is double majoring in psychology and neuroscience, is a recent winner of the ASU Changemaker Award for Volunteerism. Photo by Robert Ewing, ASU Department of Psychology Download Full Image

Manzo is a senior in the Arizona State University Department of Psychology who is double majoring in psychology and neuroscience. She is part of the star-studded Behavioral Neuroscience of Memory and Aging lab and is a recent winner of the ASU Changemaker Award for Volunteerism.

The Behavioral Neuroscience of Memory and Aging Lab, led by Presidents Professor Heather Bimonte-Nelson, investigates the roles of hormones and brain chemistry in brain function and cognition with age. Much of the research in the lab centers on the transition to menopause and cognition in females. Many of the lab members have been named Deans Medalists, Fulbright Scholarsand Barrett Award winners.

From the day I met Alyssa at a brain outreach event, I knew she was a superstar,"said Stephanie Koebele, a postdoctoral researcher in the Bimonte-Nelson lab who was holding the brain that caught Manzos attention two years ago. "She has been a wonderful asset to our lab team over the past several years. Alyssa is inquisitive, compassionate, dependable, unafraid to ask questions, radiates positivity and is an overall joy to work with. Her drive to constantly learn is palpable. I am continually inspired by her community-minded attitude and thoughtfulness about inclusivity in science and society. I am in awe of her creation of and commitment to the Swift Youth Foundation to inspire youth to pursue higher education.

Manzo's experience in the lab pushed her to think about what other options are out there, beyond basic science research.

One thing that really stuck with her was Bimonte-Nelsons work with hosting Brain Fairs for Title I schools to provide hands-on experience for underserved students. These students may not have the same resources as other students, but Bimonte-Nelson wanted to show how attainable a college degree is and why it should be a goal of theirs. Manzo and other members of the Bimonte-Nelson lab hosted the events, creating brain models with clay and pipe cleaners, teaching students about brain regions and synapses, as well as answering questions about college.

It was so impactful to see how you can show kids a really different perspective and future than they ever believed to be possible, Manzo said.

Manzo took this foundation of mentorship with her to the Swift Youth Foundation a summer camp and year-round mentoring foundation for economically disadvantaged youth. At this camp, she ran activities, games, helped instruct science in a fun way.

I wanted to do a bit more and bring the college experience to the kids to show them what college is like and why they should aspire for higher education, Manzo said.

She began the Swift Club at ASU and grew it from three members to over 40 in a little over a year. Together the Swift Club partnered with the Swift Youth Foundation to create Swift University.

Manzo and the Swift Club won the Fall Changemaker Service Award for their impact in volunteerism for running this Swift University Program for underserved communities. In this program, they led elementary students through different activities based on four college majors psychology, chemistry, physics and English. Students explored neuroscience through clay models of brains, worked through chemical equations to produce slime, conducted static electricity and wrote letters to their friends and family. These hands-on activities were designed to illustrate the wide range of fields that are available both in STEM and non-STEM majors.

Having this mentor experience is just so amazing because I also came from a Title I school. I would have loved to speak with college students about their experiences and to learn from them. I know exactly where they are coming from and I know many of the challenges they are currently facing, Manzo said. Being able to make a difference in their lives is incredibly gratifying and I am excited to show that it is possible to make it at the next level.

Not only has Manzo been a positive role-model for young students, she has been a key member of the Bimonte-Nelson lab and struck a chord with her mentor.

"It has been a joy to watch Alyssa find her passion in science,"Bimonte-Nelson said."Through the years it has become clear that her motivation for becoming a scientist is to help people with dementia and their caregivers, with a focus on inclusion of diversepopulations in scientificstudies to improve health outcomes. This young scientist thinks deeply, maintains a calm demeanor even during the highest stress periods, and asks thoughtful, relevant, and important questions reflecting her focus on helping people. Alyssa is going to be a fabulousdoctoral student, and I cannot wait to see all of the impacts she will make on the world."

Read this article:
Having a heart and brain for the community - ASU Now

Watching decision making in the brain | Stanford News – Stanford University News

In the course of deciding whether to keep reading this article, you may change your mind several times. While your final choice will be obvious to an observer youll continue to scroll and read, or youll click on another article any internal deliberations you had along the way will most likely be inscrutable to anyone but you. That clandestine hesitation is the focus of research, published Jan. 20 in Nature, by Stanford University researchers who study how cognitive deliberations are reflected in neural activity.

Stanford neuroscientists and engineers used neural implants to track decision making in the brain, in real time. (Image credit: Gil Costa)

These scientists and engineers developed a system that read and decoded the activity of monkeys brain cells while the animals were asked to identify whether an animation of moving dots was shifting slightly left or right. The system successfully revealed the monkeys ongoing decision-making process in real time, complete with the ebb and flow of indecision along the way.

I was just looking at the decoded activity trace on the screen, not knowing which way the dots were moving or what the monkey was doing, and I could tell Sania [Fong], the lab manager, Hes going to choose right, seconds before the monkey initiated the movement to report that same choice, recalled Diogo Peixoto, a former postdoctoral scholar in neurobiology and co-lead author of the paper. I would get it right 80 to 90 percent of the time, and that really cemented that this was working.

In subsequent experiments, the researchers were even able to influence the monkeys final decisions through subliminal manipulations of the dot motion.

Fundamentally, much of our cognition is due to ongoing neural activity that is not reflected overtly in behavior, so whats exciting about this research is that weve shown that we can now identify and interpret some of these covert, internal neural states, said study senior author William Newsome, the Harman Family Provostial Professor in the Department of Neurobiology at Stanford University School of Medicine.

Were opening up a window onto a world of cognition that has been opaque to science until now, added Newsome, who is also the Vincent V.C. Woo Director of the Wu Tsai Neurosciences Institute.

Neuroscience studies of decision making have generally involved estimating the average activity of populations of brain cells across hundreds of trials. But this process overlooks the intricacies of a single decision and the fact that every instance of decision making is slightly different: The myriad factors influencing whether you choose to read this article today will differ from those that would affect you if you were to make the same decision tomorrow.

Cognition is really complex and, when you average across a bunch of trials, you miss important details about how we come to our perceptions and how we make our choices, said Jessica Verhein, MD/PhD student in neuroscience and co-lead author of the paper.

For these experiments, the monkeys were outfitted with a neural implant about the size of a pinky fingernail that reported the activity of 100 to 200 individual neurons every 10 milliseconds as they were shown digital dots parading on a screen. The researchers placed this implant in the dorsal premotor cortex and the primary motor cortex because, in previous research, they found that neural signals from these brain areas convey the animals decisions and their confidence in those decisions.

Each video of moving dots was unique and lasted less than two seconds, and the monkeys reported their decisions about whether the dots were moving right or left only when prompted a correct answer given at the correct time earned a juice reward. The monkeys signaled their choice clearly, by pressing a right or left button on the display.

Inside the monkeys brains, however, the decision process was less obvious. Neurons communicate through rapid bursts of noisy electrical signals, which occur alongside a flurry of other activity in the brain. But Peixoto was able to predict the monkeys choices easily, in part because the activity measurements he saw were first fed through a signal processing and decoding pipeline based on years of work by the lab of Krishna Shenoy, the Hong Seh and Vivian W. M. Lim Professor in the School of Engineering and a professor, by courtesy, of neurobiology and of bioengineering, and a Howard Hughes Medical Institute Investigator.

Shenoys team had been using their real-time neural decoding technique for other purposes. We are always trying to help people with paralysis by reading out their intentions. For example, they can think about how they want to move their arms and then that intention is run through the decoder to move a computer cursor on the screen to type out messages, said Shenoy, who is co-author of the paper. So, were constantly measuring neural activity, decoding it millisecond by millisecond, and then rapidly acting on this information accordingly.

In this particular study, instead of predicting the immediate movement of the arm, the researchers wanted to predict the intention about an upcoming choice as reported by an arm movement which required a new algorithm. Inspired by the work of Roozbeh Kiani, a former postdoctoral scholar in the Newsome lab, Peixoto and colleagues perfected an algorithm that takes in the noisy signals from groups of neurons in the dorsal premotor cortex and the primary motor cortex and reinterprets them as a decision variable. This variable describes the activity happening in the brain preceding a decision to move.

With this algorithm, we can decode the ultimate decision of the of the monkey way before he moves his finger, let alone his arm, said Peixoto.

The researchers speculated that more positive values of the decision variable indicated increased confidence by the monkey that the dots were moving right, whereas more negative values indicated confidence that the dots were shifting left. To test this hypothesis, they conducted two experiments: one where they would halt the test as soon as the decision variable hit a certain threshold and another where they stopped it when the variable seemed to indicate a sharp reversal of the monkeys decision.

During the first experiments, the researchers stopped the tests at five randomly chosen levels and, at the highest positive or negative decision variable levels, the variable predicted the monkeys final decision with about 98 percent accuracy. Predictions in the second experiment, in which the monkey had likely undergone a change of mind, were almost as accurate.

In advance of the third experiment, the researchers checked how many dots they could add during the test before the monkey became distracted by the change in the stimulus. Then, in the experiment, the researchers added dots below the noticeable threshold to see if it would sway the monkeys decision subliminally. And, even though the new dots were very subtle, they did sometimes bias the monkeys choices toward whatever direction they were moving. The influence of the new dots was stronger if they were added early in the trial and at any point where the monkeys decision variable was low which indicates a weak level of certainty.

This last experiment, led by Jessie [Verhein], really allowed us to rule out some of the common models of decision making, said Newsome. According to one such model, people and animals make decisions based on the cumulative sum of evidence during a trial. But if this were true, then the bias the researchers introduced with the new dots should have had the same effect no matter when it was introduced. Instead, the results seemed to support an alternative model, which states that if a subject has enough confidence in a decision building in their mind, or has spent too long deliberating, they are less inclined to consider new evidence.

Already, Shenoys lab is repeating these experiments with human participants with neural dysfunctions who use these same neural implants. Due to differences between human and nonhuman primate brains, the results could be surprising.

Potential applications of this system beyond the study of decision making include investigations of visual attention, working memory or emotion. The researchers believe that their key technological advance monitoring and interpreting covert cognitive states through real-time neural recordings should prove valuable for cognitive neuroscience in general, and they are excited to see how other researchers build on their work.

The hope is that this research captures some undergraduates or new graduate students interest and they get involved in these questions and carry the ball forward for the next 40 years, said Shenoy.

Stanford co-authors include former postdoctoral scholars Roozbeh Kiani (now at New York University), Jonathan C. Kao (now at the University of California, Los Angeles) and Chand Chandrasekaran (now at Boston University); Paul Nuyujukian, assistant professor of bioengineering and of neurosurgery; previous lab manager Sania Fong and researcher Julian Brown (now at UCSF); and Stephen I. Ryu, adjunct professor of electrical engineering (also head of neurosurgery at the Palo Alto Medical Foundation). Newsome, Nuyujukian and Shenoy are also members of Stanford Bio-X and the Wu Tsai Neurosciences Institute.

This research was funded by the Champalimaud Foundation, Portugal; Howard Hughes Medical Institute; National Institutes of Health via the Stanford Medical Scientist Training Program; Simons Foundation Collaboration on the Global Brain; Pew Scholarship in Biomedical Sciences; National Institutes of Health (including a Directors Pioneer Award); McKnight Scholars Award; National Science Foundation; National Institute on Deafness and Other Communication Disorders; National Institute of Neurological Disorders and Stroke; Defense Advanced Research Projects Agency Biological Technologies Office (NeuroFAST Award); and Office of Naval Research.

To read all stories about Stanford science, subscribe to the biweeklyStanford Science Digest.

View original post here:
Watching decision making in the brain | Stanford News - Stanford University News

Treatment for cluster headaches The most severe pain – Norton Healthcare

Cluster headache medication can reduce the extreme pain of these episodic headaches, as well as the frequency.

Active periods of cluster headaches can last one week to several months, with pain-free periods of at least three months. Several headaches per day are not uncommon. The attacks average 30 minutes, but they can last anywhere from 15 minutes to three hours.

The pain associated with episodic cluster headache is the most severe pain humans can experience, said neurologist Brian M. Plato, D.O., headache and migraine specialist with Norton Neuroscience Institute. Women tell me childbirth is less painful.

Cluster headaches typically strike without warning, with excruciating pain behind one eye. In addition to pain, these headaches can cause the eye to tear up and the eyelid to droop. There can be swelling. The person experiencing a cluster headache may have a stuffy or runny nose on the affected side.

Injections of sumatriptan, which goes by the brand name Imitrex, is an effective way of stopping a cluster attack, though insurance companies typically limit patients to six doses per month, according to Dr. Plato.

Another effective way to end an attack is breathing 100% oxygen, though Medicare will not cover this for people with episodic cluster headaches, according to Dr. Plato. Private insurers tend to follow Medicares lead on what to cover, but its worth checking with your insurance provider.

Another drug, galcanezumab (brand name Emgality), has been shown to reduce the number of attacks per week. The drug doesnt end the cycle but makes it more bearable by reducing the number of attacks.

More headache patients choose the team at Norton Neuroscience Institute for treatment than any other in the area. Weve added specialists and expanded use of Norton Telehealth so you can get appointments faster.

Make an appointment today.

Call (502) 629-1234

Episodic cluster headaches are rare, affecting only one in 1,000 people. They often go undiagnosed, or they are misdiagnosed as migraines or sinusitis, according to Dr. Plato.

The cause of cluster headaches is unknown, but men are more likely to have cluster headaches than women, as are smokers and people who have a parent or sibling with cluster headaches.

Episodic cluster headaches arent associated with a particular trigger, such as stress, but drinking alcohol during a cluster period may increase the risk.

Patients who have episodic cluster headache live a part of their life in absolute fear of what happens when this comes back, Dr. Plato said. Its not uncommon the attacks will awaken individuals from sleep. When theyre in a cycle, patients will fear sleep because a couple of hours later they will awaken with a severe attack.

Originally posted here:
Treatment for cluster headaches The most severe pain - Norton Healthcare

Neuroscience Antibodies and Assays Market 2021 In-Depth Analysis of Industry Share, Size, Growth Outlook up to 2026 | Thermo Fisher, Abcam, Bio-Rad,…

It is our aim to provide our readers with report forNeuroscience Antibodies and Assays Market, which examines the industry during the period 2020 2026. One goal is to present deeper insight into this line of business in this document. The first part of the report focuses on providing the industry definition for the product or service under focus in the Neuroscience Antibodies and Assays Market report. Next, the document will study the factors responsible for hindering and enhancing growth in the industry. After covering various areas of interest in the industry, the report aims to provide how the Neuroscience Antibodies and Assays Market will grow during the forecast period.

The major vendors covered:Thermo Fisher, Abcam, Bio-Rad, Merck, Cell Signaling Technology, Genscript, Rockland Immunochemicals, BioLegend, Santa Cruz Biotechnology, Roche. and more

Get a Free Sample Copy @https://www.reportsandmarkets.com/sample-request/global-neuroscience-antibodies-and-assays-market-size-status-and-forecast-2019-2025?utm_source=neighborwebsj&utm_medium=38

The Neuroscience Antibodies and Assays Market report between the years 2020 2026 will highlight the current value of the industry. At the same time, there is also an estimate of how much this line of business will be worth at the end of the forecast period. As it is our goal to maintain high levels of accuracy at all times, we will take a look at the CAGR of the Neuroscience Antibodies and Assays Market. We make sure that all the information available in this report has excellent levels of readability. One way we achieve this target is by Neuroscience Antibodies and Assays Market segmentation. Going through the report for 2020 2026 will bring our readers up-to-date regarding this industry.

While examining the information from this document, one thing becomes clear, the elements which contribute to increase in demand for the product or service. At the same time, there will be a focus on what drives the popularity of these types of products or services. This report is for those who want to learn about Neuroscience Antibodies and Assays Market, along with its forecast for 2020 2026. Information regarding market revenue, competitive partners, and key players will also be available.

Segmentation

As discussed earlier, there is segmentation in theNeuroscience Antibodies and Assays Marketreport, to improve the accuracy and make it easier to collect data. The categories which are the dividing factors in the industry are distribution channels, application, and product or service type. With this level of segmentation, it becomes easier to analyze and understand the Neuroscience Antibodies and Assays Market. At the same time, there is emphasis on which type of consumers become the customers in this industry. When it comes to distribution channels, the Neuroscience Antibodies and Assays Market report looks at the different techniques of circulation of the product or service.

Regional Overview

In this part of theNeuroscience Antibodies and Assays Marketreport, we will be taking a look at the geographical areas and the role they play in contributing to the growth of this line of business. The areas of interest in this document are as follows Middle East and Africa, South and North America, Europe, and Asia Pacific. From the Neuroscience Antibodies and Assays Market report, it becomes clear which region is the largest contributor.

Latest Industry News

From thisNeuroscience Antibodies and Assays Marketreport, the reader will also get to learn about the latest developments in the industry. The reason is that these products or services have the potential to disrupt this line of business. If there is information about company acquisitions or mergers, this information will also be available in this portion of the Neuroscience Antibodies and Assays Market report.

If you have any special requirements about this Neuroscience Antibodies and Assays Market report, please let us know and we can provide custom report.

Inquire More About This Report @https://www.reportsandmarkets.com/enquiry/global-neuroscience-antibodies-and-assays-market-size-status-and-forecast-2019-2025?utm_source=neighborwebsj&utm_medium=38

About Us:-

ReportsAndMarkets.comallocates the globally available market research and many company reports from reputed market research companies that are a pioneer in their respective domains. We are completely an autonomous group and serve our clients by offering the trustworthy available research stuff, as we know this is an essential aspect of Market Research.

Contact Us

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

https://neighborwebsj.com/

Go here to read the rest:
Neuroscience Antibodies and Assays Market 2021 In-Depth Analysis of Industry Share, Size, Growth Outlook up to 2026 | Thermo Fisher, Abcam, Bio-Rad,...

NEUROSCIENCE ANTIBODIES AND ASSAYS Market Size NeighborWebSJ – NeighborWebSJ

Fort Collins, Colorado This report presents the NEUROSCIENCE ANTIBODIES AND ASSAYS Market Size (value, consumption and production) and breaks down the breakdown (data status 2015-2020 and forecast to 2027) by manufacturer, region, type, and application. This study also analyzes the market status, future trends, market drivers, market shares, growth rate, opportunities and challenges, sales channels, []

More here:
NEUROSCIENCE ANTIBODIES AND ASSAYS Market Size NeighborWebSJ - NeighborWebSJ

Neuroscience Industry 2020 Includes The Major Application Segments And Size In The Global Market To 2027 Reviewindependent – Reviewindependent

The Global Neuroscience Market analysis report published on IndustryGrowthInsights.com is a detailed study of market size, share and dynamics covered in XX pages and is an illustrative sample demonstrating market trends. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact is covered in the report. It covers the entire market with an in-depth study on revenue growth and profitability. The report also delivers on key players along with strategic standpoint pertaining to price and promotion.

Get FREE Exclusive PDF Sample Copy of This Report: https://industrygrowthinsights.com/request-sample/?reportId=168030

The Neuroscience Market report entails a comprehensive database on future market estimation based on historical data analysis. It enables the clients with quantified data for current market perusal. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and regional analysis. Listed out are key players, major collaborations, merger & acquisitions along with upcoming and trending innovation. Business policies are reviewed from the techno-commercial perspective demonstrating better results. The report contains granular information & analysis pertaining to the Global Neuroscience Market size, share, growth, trends, segment and forecasts from 2020-2027.

With an all-round approach for data accumulation, the market scenarios comprise major players, cost and pricing operating in the specific geography/ies. Statistical surveying used are SWOT analysis, PESTLE analysis, predictive analysis, and real-time analytics. Graphs are clearly used to support the data format for clear understanding of facts and figures.

Customize Report and Inquiry for The Neuroscience Market Report: https://industrygrowthinsights.com/enquiry-before-buying/?reportId=168030

Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Primary research, interviews, news sources and information booths have made the report precise having valuable data. Secondary research techniques add more in clear and concise understanding with regards to placing of data in the report.

The report segments the Global Neuroscience Market as:Global Neuroscience Market Size & Share, by Regions

Global Neuroscience Market Size & Share, by ProductsWhole Brain ImagingNeuro-MicroscopyElectrophysiology TechnologiesNeuro-Cellular ManipulationStereotaxic SurgeriesAnimal BehaviorOtherWhole Brain Imaging, Neuro-Microscopy, and Electrophysiology Technologies are the top three types of neuroscience, with a combined market share of 62%Neuroscienc

Global Neuroscience Market Size & Share, ApplicationsHospitalsDiagnostic LaboratoriesResearch InstitutesOtherNeuroscience is applied mostly in the hospital with a market share of 47%. It is followed by Research Institutes and Diagnostic Laboratories

Key PlayersGE HealthcareSiemens HealthineersNoldus Information TechnologyMightex BioscienceThomas RECORDING GmbHBlackrock MicrosystemsTucker-Davis TechnologiesPlexonPhoenix Technology GroupNeuroNexusAlpha OmegaNeuroscienc

Avail the Discount on this Report @ https://industrygrowthinsights.com/ask-for-discount/?reportId=168030

IndustryGrowthInsights offers attractive discounts on customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

About IndustryGrowthInsights:INDUSTRYGROWTHINSIGHTS has set its benchmark in the market research industry by providing syndicated and customized research report to the clients. The database of the company is updated on a daily basis to prompt the clients with the latest trends and in-depth analysis of the industry. Our pool of database contains various industry verticals that include: IT & Telecom, Food Beverage, Automotive, Healthcare, Chemicals and Energy, Consumer foods, Food and beverages, and many more. Each and every report goes through the proper research methodology, validated from the professionals and analysts to ensure the eminent quality reports.

Contact Info: Name: Alex MathewsAddress: 500 East E Street, Ontario, CA 91764, United States.Phone No: USA: +1 909 545 6473Email: [emailprotected]Website: https://IndustryGrowthInsights.com

Read more from the original source:
Neuroscience Industry 2020 Includes The Major Application Segments And Size In The Global Market To 2027 Reviewindependent - Reviewindependent

Size of synapses determines the strength of information transmission – News-Medical.net

Nerve cells communicate with one another via synapses. Neuroscientists at the University of Zurich and ETH Zurich have now found that these connections seem to be much more powerful than previously thought. The larger the synapse, the stronger the signal it transmits. These findings will enable a better understanding of how the brain functions and how neurological disorders arise.

The neocortex is the part of the brain that humans use to process sensory impressions, store memories, give instructions to the muscles, and plan for the future. These computational processes are possible because each nerve cell is a highly complex miniature computer that communicates with around 10,000 other neurons. This communication happens via special connections called synapses.

Researchers in Kevan Martin's laboratory at the Institute of Neuroinformatics at the University of Zurich (UZH) and ETH Zurich have now shown for the first time that the size of synapses determines the strength of their information transmission.

Larger synapses lead to stronger electrical impulses. Finding this relationship closes a key knowledge gap in neuroscience. The finding is also critical for advancing our understanding of how information flows through our brain's circuits, and therefore how the brain operates."

Kevan Martin, Institute of Neuroinformatics, University of Zurich (UZH)

First, the neuroscientists set about measuring the strength of the synaptic currents between two connected nerve cells. To do this, they prepared thin sections of a mouse brain and, under a microscope, inserted glass microelectrodes into two neighboring nerve cells of the neocortex. This enabled the researchers to artificially activate one of the nerve cells and at the same time measure the strength of the resulting synaptic impulse in the other cell. They also injected a dye into the two neurons to reconstruct their branched-out cellular processes in three dimensions under a light microscope.

Since synapses are so tiny, the scientists used the high resolution of an electron microscope to be able to reliably identify and precisely measure the neuronal contact points. First, in their light microscope reconstructions, they marked all points of contact between the cell processes of the activated neuron that forwarded the signal and the cell processes of the neuron that received the synaptic impulse. Then, they identified all synapses between the two nerve cells under the electron microscope. They correlated the size of these synapses with the synaptic impulses they had measured previously. "We discovered that the strength of the synaptic impulse correlates directly with the size and form of the synapse," says lead author Gregor Schuhknecht, formerly a PhD student in Kevan Martin's team.

This correlation can now be used to estimate the strength of information transmission on the basis of the measured size of the synapse. "This could allow scientists to use electron microscopy to precisely map the wiring diagrams of the neocortex and then simulate and interpret the flow of information in these wiring diagrams in the computer," explains Schuhknecht. Such studies will enable a better understanding of how the brain functions under normal circumstances and how "wiring defects" can lead to neurodevelopmental disorders.

The team was also able to resolve another longstanding puzzle in neuroscience. Until now, the conventional doctrine had been that only a single neurotransmitter-filled packet (a so-called vesicle) is released at a synapse upon activation. The researchers were able to use a novel mathematical analysis to prove that each synapse in fact has several sites that can release packets of neurotransmitter simultaneously. "This means that synapses are much more complex and can regulate their signal strength more dynamically than previously thought. The computational power and storage capacity of the entire neocortex therefore seems to be much greater than was previously believed", says Kevan Martin.

Source:

Journal reference:

Holler, S., et al. (2020) Structure and function of a neocortical synapse. Nature. doi.org/10.1038/s41586-020-03134-2.

Link:
Size of synapses determines the strength of information transmission - News-Medical.net

What is representation in the human brain and AI systems? | OUPblog – OUPblog

You know the way Google search will sometimes finish your sentences for you? Or, when youre typing an email, theres some ghostly predictive text that floats just in front of your cursor? Well, theres a new kid on the block that makes these gadgets look like toy tricks out of a Christmas cracker. Give it a sentence of Jane Austen and it will finish the paragraph in the same style. Give it a philosophical conjecture and it will fill the page with near-coherent academic ruminations.GPT-3is essentially just predicting what words should come next, following on from the prompt its been given. That the machine does so well is partly because its been trained on an unimaginably huge database of samples of English (reputedly, $13 million worth of training). A similar machine can predict, from a sequence of amino acids, how the resulting protein will fold, short-cutting months of lab work and in some cases years of human ingenuity (AlphaFold). But what is going on inside the machine? What is it keeping track of inside its huge neural network brain?

We face the same question, of course, when we look at the human braina seemingly inscrutable organ of even greater complexity. Yet neuroscience is beginning to make sense of whats going on inside: of patterns of activity distributed across millions of neurons, flowing into other patterns; coupling and modulating; unfolding in a way that opens the organism to the world outside, projected through its inner space of needs and drives, bathed in the wash of past experience, reaching out to control and modify that world to its own agenda. We can now see what some of these patterns of activity are, and we have an inkling of what they are doing, of how they track the environment, and subserve behaviour.

Neuroscientists are recording these patterns with new techniques. But what do the patterns mean? How should they be understood? Neuroscience is increasingly tackling these questions by asking what the activation patternsrepresent. For example,representational similarity analysis(RSA) is used to ask whether the human brain processes images in the same way as the brain of the macaque monkey. Surprisingly,similar techniquescan be used to compare the human brain to an AI computer system trained to perform the same task. These AIs are deep neural networks, cousins of the seemingly unfathomable GPT-3 and AlphaFold brains we met at the start. Astoundingly, it turns out that sometimes the deep neural network is processing images in roughly the same way as the human brain. In a general sense, both are performing the same computations en route to working out that they are looking at a picture of two cats on a sofa. In other cases, we see the brain using ahexagonal codeto represent physical spaceand more abstract conceptual spacesand to reason about them.

All of this means that representation has become something of a hot topic in cognitive neuroscience. Representation has always been around, of course, working away in the foundations ever since the cognitive revolution showed that we could explain behaviour in terms of internal processing without having to feel embarrassed about intelligent homunculi or ghosts in the machine. What we have now are much better ways to see those representations in the brain and to marry them up with the computational story about how the organism intelligently deals with its environment.

representation is the crucial link for connecting brain activity with functional, adaptive behaviour

What we still need is a proper understanding of what representation isan understanding of how there come to be things in the head which stand in for, and allow creatures to deal with, things in their environment. A once-unconventional idea in contemporary philosophy (originating with Ruth Millikan, David Papineau, and Karen Neander) is that this is intimately tied up with functionbiological functions based on natural selection. Although a connection to function may have always been implicit in some scientific practice, it is now being recognised explicitly (Hunt et al. 2012,Richards et al. 2019). For example, in a recent manifesto for the role of representation in computational cognitive neuroscience, Kriegeskorte and Diedrichsen (2019) argue that representation is the crucial link for connecting brain activity with functional, adaptive behaviour. Meanwhile in philosophy, appealing to natural teleology to explain representation has moved into the mainstream, being embraced by researchers from diverse disciplinary starting points (David Haig,Robert Williams), alongside recent landmark contributions from early advocates (Karen Neander,Ruth Millikan).

The devil is in the details, of course, but it is beginning to look as if we have the main ingredients in place: internal states that stand in useful relations to things in the environment, internal processing which relies on those relations, and the functions that serves for the organism. Just as the cognitive sciences come to lean on representation ever more heavily, it seems that we now have the resources to understand this foundational notion.

Feature image by issaronow

Read more from the original source:
What is representation in the human brain and AI systems? | OUPblog - OUPblog

HistoIndex Explores the Clinical Utility of Stain-free AI Digital Pathology Platform in 388 Patients with Triple-Negative Breast Cancer (TNBC) – The…

Assessing Collagen Features at a Finer Level of Detail

In a collaborative study involving scientists from the Institute of Molecular and Cell Biology (IMCB) in Singapore and TNBC pathologists from the Singapore General Hospital (SGH), unstained biopsies from 388 TNBC patients were scanned using HistoIndex's AI-based SHG platform and analyzed to extract different collagen features from the SHG images at a finer level of detail. Findings published in the leading peer-reviewed oncology journal, Breast Cancer Research [3], showed a strong correlation between several imaging features and clinicopathological characteristics. Aggregation of collagen fibers, collagen fiber density and the length of dispersed thin collagen fibers were key collagen-associated parameters revealed to be of prognostic value based on the patient cohort and clinical outcomes. Furthermore, analyzing the aggregated thick collagen (ATC) fibers and dispersed thin collagen (DTC) fibers (as shown in Figure 1) provided a novel understanding of collagen remodeling during cancer progression.

Says Professor Tan Puay Hoon, Chairman, Division of Pathology, and Senior Consultant, Department of Anatomical Pathology, SGH, and lead pathologist of the study, "Critical biomarkers in TNBC are needed to stratify patients and predict clinical outcomes. Technological advances in pathology such as SHG assessment may improve the characterization of detailed and minute changes in important collagen features within the tumor stromal microenvironment such as the collagen structure, density and length. These are important parameters that could possibly enhance pathological assessment and allow for a clearer understanding of the relationship between collagen features and tumor progression."

Evaluating Therapeutic Efficacy with Key Collagen Parameters

The advantages of these novel collagen parameters make the platform a valuable asset in existing and future TNBC studies that are currently monitoring therapeutic responses in their exploration of targeted treatments. For instance, an ongoing collaboration between HistoIndex and a team at the Memorial Sloan Kettering Cancer Center (MSK), led by Professor Linda Vahdat, Chief of Medical Oncology and Clinical Director of Cancer Services at the MSK Physicians at Norwalk Hospital, is currently investigating influencing the tumor microenvironment with anti-copper therapy (copper depletion) for patients with breast cancer who are at a high risk of a relapse.

Copper encourages the growth of the blood vessels that feed dormant, and later active, cancer cells, and is also needed by certain cancer molecules to communicate with and influence the tumor microenvironment. Subsequently, this element is a necessary resource to build a collagen scaffolding that cancer cells populate as they become aggressive. Having spent many years examining copper depletion in TNBC studies, Prof. Vahdat has previously explained the role of copper in triggering metastasis, and how the collagen scaffolding that houses the tumor breaks down once copper is pulled out of the system [4].

Says Prof. Vahdat, "Collagen within the tumor microenvironment represents an under-explored predictor of treatment outcome. Preliminary data from our group suggests that we can normalize the collagen microenvironment with a copper depletion strategy rendering an inhospitable environment for metastases. With this collaboration with HistoIndex, we hope to be able to predict those primary tumors that are amenable to this treatment strategy."

About TNBC

The term Triple-Negative Breast Cancer refers to the fact that the cancer cells do not possess estrogen or progesterone receptors and also do not overexpress the protein called HER2. A patient is diagnosed with this form of breast cancer when the cells test "negative" for all three receptors. TNBC differs from other types of invasive breast cancer as they progress faster, have limited targeted treatments, and a generally bleak prognosis. According to the American Cancer Society, TNBC accounts for about 10-15% of all breast cancers and is more common in women younger than the age 40, who are African-American, or women who have a BRCA1 mutation [5].

References

SOURCE Histoindex Pte. Ltd.

Home

Read more from the original source:
HistoIndex Explores the Clinical Utility of Stain-free AI Digital Pathology Platform in 388 Patients with Triple-Negative Breast Cancer (TNBC) - The...

Organoids give insight into the development of cervical cancer – BioNews

25 January 2021

Molecular changes that give rise to cervical cancer have been identified using novel 'organoid' models.

Published in Nature Cell Biology, researchers in Germany have developed an organoid model of the cervix, providing them with a unique way to study its normal biology and better understand why cancers develop.

'These fundamental findings form a basis for further understanding of the mechanisms involved in carcinogenesis at these metaplastic sites. To study how human papillomavirus (HPV), together with superseding bacterial infections, plays a key role in transforming cells to malignancy,' said Dr Cindrilla Chumduri from the Biocentre at the University of Wrzburg, who led the study.

Organoids are tiny 3D structures made of cells just a few millimetres in size that are artificially developed to closely resemble whole organs. They are increasingly used in medical research to allow scientists to study life processes and the effect of drugs.

Prior to this new study, it was known that the cervix has two regions covered by two different types of epithelial cells so called 'squamous epithelia' and 'columnar epithelia'. The boundaries between these two different cell types are called transition zones, and 90 perecent of cervical cancers originate at these sites. However, it was not known exactly how these two cell populations and their boundaries are ordinarily kept distinct in a healthy cervix, or why this is a hotspot for cancer development.

Using the organoid structures, the researchers discovered that instead of the two different epithelial cell types developing from the same stem cells, they are in fact derived from two discrete stem cell populations.

Complex interactions between these stem cells and their surrounding microenvironment were found to be important for keeping the two types of cells separate and for ensuring a healthy cervical architecture. This is achieved using the Wnt signaling pathway proteins known for their role in cellular differentiation, among other processes.

The researchers also showed that disrupting Wnt signalling can alter the homeostasis seen in the cervix, allowing one type of epithelium cell to replace the other an early event in cancer development termed metaplasia. Different types of cervical cancers can develop depending on which epithelial cell population is displaced.

It is hoped that this improved understanding of the fundamental biology of the cervix and the molecular changes seen in cervical metaplasia will help improve our understanding of how certain viral and bacterial infections principally HPV cause cervical cancer.

Dr Chumduri also added, 'these critical insights can help to develop diagnostics for the early detection of these two tumour forms and new therapeutic strategies'.

More here:
Organoids give insight into the development of cervical cancer - BioNews